FDA Crackdown On Anti-Aging Imports Signals "Major Enforcement Initiative"
This article was originally published in The Rose Sheet
Increased scrutiny of anti-aging products entering the U.S. presages "a major enforcement initiative" against illegal cosmetic claims that will impact domestic personal-care firms, large and small, according to attorney and ex-FDAer Benjamin L. England
You may also be interested in...
Nu Skin aims to achieve “higher levels of penetration” in China by expanding its direct-selling platform to additional provinces and tripling the number of stores and sales centers it operates by 2017. Meanwhile, short-seller Citron Research directs FDA and FTC to advertising for Nu Skin’s ageLOC line, which it asserts is rife with “unsubstantiated medical claims.”
Following allegations from short seller Citron Research that it operates an illegal “pyramid compensation scheme” in China, Nu Skin gives investors a peek into its business model. The firm recorded sales growth of 40% in its second quarter, driven by a 152% jump in China, and “the best is yet to come,” Nu Skin says.
FDA stepped up its surveillance of cosmetic imports over the summer, subjecting those importing products to the U.S. to increased scrutiny of color additives, labeling and permitted uses.